AKT1 and central nervous system cancer: A pre-clinical analysis conducted by Vishal et al. suggested that JQ1 treatment could induce Akt suppression only at longer time intervals, indicating that the Akt pathway plays a context-depended role in JQ1 treatment of glioma cells [5].